These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8561840)

  • 1. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metaanalysis of controlled trials of neuroleptic treatment in dementia.
    Schneider LS; Pollock VE; Lyness SA
    J Am Geriatr Soc; 1990 May; 38(5):553-63. PubMed ID: 1970586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
    Devanand DP; Marder K; Michaels KS; Sackeim HA; Bell K; Sullivan MA; Cooper TB; Pelton GH; Mayeux R
    Am J Psychiatry; 1998 Nov; 155(11):1512-20. PubMed ID: 9812111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
    Riva E; Nobili A; Trecate F
    Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the elderly suffering from psychosis and dementia.
    Sunderland T
    J Clin Psychiatry; 1996; 57 Suppl 9():53-6. PubMed ID: 8823351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the agitation of late-life psychosis and Alzheimer's disease.
    Salzman C
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():25s-28s. PubMed ID: 11520475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Franco KN; Messinger-Rapport B
    J Am Med Dir Assoc; 2006 Mar; 7(3):201-2. PubMed ID: 16503315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.
    Lawlor B; Bhriain SN
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S2-6. PubMed ID: 11748783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP; Schneider LS
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives.
    Sultzer DL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):78-90. PubMed ID: 14566100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
    Lemke MR
    J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.